Skip to content

Direxion Daily Biotech Top 5 Bull 2X ETF

TBXUNYSE ArcaDThis fund multiplies its index's move each day and resets that multiple daily. Because daily returns compound, its long-run return can differ from the headline multiple.

$35.92−1.09 (−2.95%)

As of Oct 13, 2026, 12:55 PM

Intraday session: down, 2 prints from 37.01 to 35.92. Range 35.92 to 37.01. Use the arrow keys to read each point.36.2036.4036.6036.8010 AM12 PM2 PM4 PM
Expense ratio
6.27%
Fund size
$3M
1Y total return
+44.2%
Yield · Last 12 months
Data unavailable
Holdings
11
Avg volume · 30D
0M sh
NAV per share
$36.99
52W range
low $25.71high $45.88
Launched

The ETF.net TBXU Grade

Based on 4 of 6 pillars

D

Score 27 out of 100

Rank
87 of 99
Six-pillar profile for TBXU. Scores out of 100: Cost 2, Risk 62, Mission not scored, Tradability 38, Holdings not scored, Durability 41. Strongest: Risk (62). Weakest: Cost (2). Based on 4 of 6 pillars.

Score 27 of 100 falls in the D band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

Very small fund, grade capped at C.

The cap holds the Score at 40 or below, so B and A are out of reach.

The pillars earned
27
This cap took
−0
Published Score
27 Grade D
  • Cost

    The fund’s net expense ratio, ranked against its category.
    F2 out of 100
    Rank 97 of 99
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    B62 out of 100
    Rank 30 of 96
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    D38 out of 100
    Rank 67 of 99
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    Not scored
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    C41 out of 100
    Rank 63 of 99

Our read on TBXU

ETF.net Research

DMost leveraged funds double a whole sector. This one doubles the daily move of just five biotech names, equally weighted. A 2025 Direxion launch built for very short holding periods, with a fee to match its narrowness.

Stated mandate

The fund seeks daily results equal to 200% of the NYSE Biotechnology Top 5 Equal Weight Index before fees and expenses.

Why people hold it

  1. 01Concentration by design: it aims for 200% of the daily move of an index of five biotech names, so you get the sector's household names without a long tail of micro caps.direxion.com
  2. 02Equal weighting means each of the five stocks carries the same load, so one giant does not quietly become the whole fund.direxion.com
  3. 03The mandate is spelled out in the fund's own documents: a rules-based index (BIOEW5), a stated 2x daily multiple, and a standard 1940 Act fund wrapper.

Worth knowing

  1. 01Cost is the headline trade-off: a 6.27% expense ratio, while the largest leveraged funds (FAS, QLD) sit near 1%.
  2. 02The 2x target resets daily. Hold past a day and compounding takes over, so multi-day results can diverge widely from twice the index.
  3. 03Small and thinly traded since its 2025 launch, which can mean wider spreads and a short record to judge it on.

TBXU Holdings

As of Oct 13, 2026
Asset class
Stocks
Holdings
11
Top-10 weight
97%
Largest holding
BIOEW5 Swap Asset Leg (BIOEW5BCL)21.9%

Geography

  • United States83.04%
  • Netherlands16.96%
The fund’s holdings, weight-ordered — page 1 of 1.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001—BIOEW5 Swap Asset Leg (BIOEW5BCL)21.88%5,565$2M1
002—BIOEW5 Swap Asset Leg (BIOEW5MLL)19.93%5,069$1M1
003—BIOEW5 Swap Asset Leg (BIOEW5CTL)15.33%3,898$1M1
004—Dreyfus Govt Cash Man Ins13.08%908,971$909K108
005AMGNAmgen Inc5.06%847$351K491
006GILDGilead Sciences Inc4.84%2,224$336K492
007VRTXVertex Pharmaceuticals Inc4.56%621$317K422
008—Goldman Finl Sq Trsry Inst 5064.52%314,137$314K98
009REGNRegeneron Pharmaceuticals4.40%410$306K411
010ARGXArgenx SE - Adr3.85%324$267K70
011—Goldman Sachs Fin Gov 465 Institut2.57%178,600$179K76

Showing 1–11 of 11 holdings

TBXU Performance

Launched Oct 1, 2025

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.Not enough history yet.
TBXU$14,422
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. TBXU $14,422. SPY $12,044. Use the arrow keys to read each point.$9,123$13,784$18,446Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for TBXU. Periods over one year show the average yearly return.
PeriodTBXU
Year to date+20.4%
1 month−3.2%
3 months+15.5%
1 year+44.2%
3 yearsFund is under 3 years oldper year—
5 yearsFund is under 5 years oldper year—
10 yearsFund is under 10 years oldper year—

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for TBXU
YearReturn barTBXU
2026 YTD+20.4%
2025+18.2%

Since listing, Oct 1, 2025

TBXU in the news

Filtered to TBXU · Leveraged Long (2x & Other)

TBXU Dividends

Last payment
$0.14 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution data unavailable.

Distribution history

2025–2026

One bar per payment. 5 payments from 2025 to 2026 YTD. Dec 10, 2025 $0.31; Dec 23, 2025 $0.10; Mar 24, 2026 $0.10; Jun 23, 2026 $0.11; Sep 22, 2026 $0.14. Use the arrow keys to read each point.20252026YTD
Ex-datePay dateAmount per share
Sep 22, 2026Sep 29, 2026$0.14
Jun 23, 2026Jun 30, 2026$0.11
Mar 24, 2026Mar 31, 2026$0.10
Dec 23, 2025Dec 31, 2025$0.10
Dec 10, 2025Dec 17, 2025$0.31

TBXU Risk

This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.

How much the fund’s monthly returns vary, scaled to a year.
—
No data available
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
—
No data available
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−26.5%
12 months · trough Jun 2026
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
−0.18
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

TBXU Cost

Expense ratio6.27%
  • The middle half of Leveraged Long (2x & Other) funds
  • Median 1.00%

92 of the 95 Leveraged Long (2x & Other) funds charge less.

TBXU costs $627.00 a year on $10,000. The median Leveraged Long (2x & Other) fund costs $100.00.

Other funds in Leveraged Long (2x & Other)